Read our latest announcements
Filter by year:
Modus Therapeutics today announces that the company has approval from the regulatory authority in India to start a Phase II study with sevuparin.
Sankt Eriksgatan 117,
SE-113 43 Stockholm, Sweden
© 2019 Modus Therapeutics. | All Rights Reserved.